2cureX - Individualizing Cancer Treatment
2cureX is about improving cancer treatment with the individual patient in focus
By testing the patient’s cancer cells for their sensitivity against approved anti-cancer drugs, IndiTreat® helps the oncologist in selecting the most effective treatment for the individual cancer patient.
IndiTreat® does not predict; but measures the treatment effectiveness and resistance for the individual cancer patient. The right individual cancer treatment saves the patient from unnecessary side effects and provides cost efficiency in drug-spending.
To establish IndiTreat® as the global standard for measuring an individual cancer patient’s response to different drug therapy options.
To make a real difference for individual cancer patients around the world by matching the most optimal therapy with the individual treatment needs.
News and Press Releases
Press releases regulatory